Home  ⁄  Press Release   ⁄   Wockhardt receives QIDP designation for its new Drug WCK 4873 from U.S. FDA

Wockhardt receives QIDP designation for its new Drug WCK 4873 from U.S. FDA

Leave a Reply

Your email address will not be published. Required fields are marked *